DalsnaFinance › IPOs › Bolt Biotherapeutics › IPO
Bolt Biotherapeutics, Inc. completed its initial public offering on NASDAQ on February 5, 2021, pricing at $20.00 a share.
| Ticker | BOLT |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | February 5, 2021 |
| Offering price | $20.00 |
| Shares offered | 11,500,000 |
| Total raised | $230M |
Bolt Biotherapeutics, Inc. sold 11,500,000 shares at $20.00 each on NASDAQ. Multiplied out, that is $230 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $230 million total recorded for the deal.
Bolt Biotherapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Bolt Biotherapeutics, Inc.. This page is general information, not investment advice.